These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35063592)
21. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation. Cuvelier B; Eloy P; Loira-Pastoriza C; Ucakar B; Sanogo AA; Dupont-Gillain C; Vanbever R Int J Pharm; 2015 Nov; 495(2):981-90. PubMed ID: 26456267 [TBL] [Abstract][Full Text] [Related]
22. Integrated continuous manufacturing of inhalable remdesivir nanoagglomerate dry powders: Design, optimization and therapeutic potential for respiratory viral infections. Chan HW; Lee HW; Chow S; Lam DCL; Chow SF Int J Pharm; 2023 Sep; 644():123303. PubMed ID: 37579825 [TBL] [Abstract][Full Text] [Related]
23. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537 [TBL] [Abstract][Full Text] [Related]
24. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders. Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery. Gomez M; McCollum J; Wang H; Bachchhav S; Tetreau I; Gerhardt A; Press C; Kramer RM; Fox CB; Vehring R Vaccine; 2021 Aug; 39(35):5025-5036. PubMed ID: 34256969 [TBL] [Abstract][Full Text] [Related]
26. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols. Kaewjan K; Srichana T Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092 [TBL] [Abstract][Full Text] [Related]
27. The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin. Barazesh A; Gilani K; Rouini M; Barghi MA Daru; 2020 Jun; 28(1):75-85. PubMed ID: 31808069 [TBL] [Abstract][Full Text] [Related]
28. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257 [TBL] [Abstract][Full Text] [Related]
29. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying. Lu W; Rades T; Rantanen J; Yang M Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050 [TBL] [Abstract][Full Text] [Related]
30. Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach. Ferrati S; Wu T; Fuentes O; Brunaugh AD; Kanapuram SR; Smyth HDC AAPS PharmSciTech; 2018 Oct; 19(7):2755-2766. PubMed ID: 29488193 [TBL] [Abstract][Full Text] [Related]
31. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252 [TBL] [Abstract][Full Text] [Related]
32. Dry powder aerosols to co-deliver antibiotics and nutrient dispersion compounds for enhanced bacterial biofilm eradication. Sommerfeld Ross S; Gharse S; Sanchez L; Fiegel J Int J Pharm; 2017 Oct; 531(1):14-23. PubMed ID: 28826725 [TBL] [Abstract][Full Text] [Related]